InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
68,872.24
(
-0.60%
)
Post# of 22
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Pieterpanne

Send PM Follow Ignore
Followers 12
Posts 594
Boards Moderated 0
Alias Born 10/12/2009

Pieterpanne

Re: Pieterpanne post# 3

Monday, 10/06/2014 5:36:30 PM

Monday, October 06, 2014 5:36:30 PM

Post# of 22
Outside News Sources
Publish Date Headline
Oct 6, 2014 Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia
Sep 9, 2014 Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma
Sep 4, 2014 Sunesis to Present at the 2014 Morgan Stanley Global Healthcare Conference
Aug 6, 2014 Sunesis to Present at the 2014 Wedbush Life Sciences Management Access Conference
Aug 5, 2014 Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights
Jul 29, 2014 Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 Financial Results and Recent Highlights
Jul 9, 2014 Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo(TM) (Vosaroxin) for AML

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up